Thema
Antibodies, Monoclonal, Humanized
3.838
Receptor, ErbB-2
EC 2.7.10.1
3.837
Journal Article
3.493
Trastuzumab
3.433
P188ANX8CK
3.428
Antibodies, Monoclonal
1.904
Antineoplastic Agents
1.785
Research Support, Non-U.S. Gov't
1.637
ERBB2 protein, human
1.611
Review
720
pertuzumab
618
K16AIQ8CTM
613
Quinazolines
445
Biomarkers, Tumor
411
Lapatinib
390
0VUA21238F
385
Research Support, N.I.H., Extramural
369
Multicenter Study
350
Taxoids
335
Paclitaxel
309
P88XT4IS4D
308
ErbB Receptors
287
Clinical Trial, Phase II
281
Randomized Controlled Trial
264
Docetaxel
263
15H5577CQD
262
Ado-Trastuzumab Emtansine
236
SE2KH7T06F
236
Comparative Study
214
Receptors, Estrogen
211
Case Reports
205
Comment
201
14083FR882
199
Maytansine
199
Fluorouracil
183
U3P01618RT
183
EC 2.7.11.1
180
Protein Kinase Inhibitors
180
HER2
177
Immunoconjugates
165
0W860991D6
160
Deoxycytidine
160
Letter
152
Clinical Trial, Phase III
150
6804DJ8Z9U
149
Capecitabine
149
Klinische Studie
142
Cyclophosphamide
135
8N3DW7272P
133
mehr ...